Amifostine Induces Antioxidant Enzymatic Activities in Normal Tissues and a Transplantable Tumor That Can Affect Radiation Response

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 3, 2009, Pages 886-896

  Grdina, David J ^a   Murley, Jeffrey S ^a   Kataoka, Yasushi ^a   Baker, Kenneth L ^a   Kunnavakkam, Rangesh ^a   Coleman, Mitchell C ^b   Spitz, Douglas R ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Amifostine; Catalase; Glutathione peroxidase; Manganese superoxide dismutase; Tumor

Indexed keywords

HISTOLOGY; MANGANESE; OXYGEN; PLANTS (BOTANY); RADIATION PROTECTION; SIMULATED ANNEALING;

AMIFOSTINE; CATALASE; GLUTATHIONE PEROXIDASE; MANGANESE SUPEROXIDE DISMUTASE; TUMOR;

TUMORS;

AMIFOSTINE; CATALASE; GLUTATHIONE PEROXIDASE; MANGANESE SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER GRAFT; CANCER RADIOTHERAPY; CELL SUSPENSION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INDUCTION; FLOW CYTOMETRY; HEART; HISTOPATHOLOGY; LIVER; LUNG; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PROTECTION; RADIATION RESPONSE; RADIOSENSITIVITY; SINGLE DRUG DOSE; SMALL INTESTINE; SPLEEN; TUMOR CELL;

AMIFOSTINE; ANIMALS; CATALASE; FEMALE; GLUTATHIONE PEROXIDASE; LIVER; LUNG; MERCAPTOETHYLAMINES; MICE; MICE, INBRED C3H; MYOCARDIUM; PANCREAS; RADIATION TOLERANCE; RADIATION-PROTECTIVE AGENTS; SARCOMA, EXPERIMENTAL; SUPEROXIDE DISMUTASE;

EID: 59649090281     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.061     Document Type: Article

References (35)

1. Kouvaris J.R., Kouloulias V.E., and Vlahos L.J. Amifostine: The first selective-target and broad-spectrum radioprotector. Oncologist 12 (2007) 738-747
2. Smoluk G.D., Fahey R.C., Calabro-Jones, et al. Radioprotection of cells in culture by WR2721 and derivatives: Form of the drug responsible for protection. Cancer Res 48 (1988) 3641-3647
3. Giambarresi L., and Jacobs A.J. Radioprotectants. In: Conklin J.J., and Walker R.I. (Eds). Military radiobiology (1987), Academic Press, Orlando, FL 265-301
4. Das K.C., Lewis-Molock Y., and White C.W. Activation of NF-Kb and elevation of MnSOD gene expression by thiol reducing agents in lung adenocarcinoma (A549) cells. Am J Physiol 269 (1995) L588-L602
5. Antras-Ferry J., Maheo K., Chevanne M., et al. Oltipraz stimulates the transcription of the manganese superoxide dismutase gene in rat hepatocytes. Carcinogenesis 18 (1997) 2113-2117
6. Sun J., Chen Y., Li M., et al. Role of antioxidant enzymes on ionizing radiation resistance. Free Radic Biol Med 24 (1998) 586-593
7. Epperly M.W., Gretton J.E., Sikora C.A., et al. Mitochondrial localization of superoxide dismutase is required for decreasing radiation-induced cellular damage. Radiat Res 160 (2003) 568-578
8. Guo G., Yan-Sanders Y., Lyn-Cook B.D., et al. Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol Cell Biol 23 (2003) 2362-2378
9. Greenberger J.S., and Epperly M.W. Antioxidant gene therapeutic approaches to normal tissue radioprotection and tumor radiosensitization. In Vivo 21 (2007) 141-146
10. Niu Y., Epperly M.W., Shen H., et al. Intraesophageal MnSOD-plasmid liposome enhances engraftment and self-renewal of bone marrow derived progenitors of esophageal squamous epithelium. Gene Ther 15 (2008) 347-356
11. Zhang X., Epperly M.W., Kay M.A., et al. Radioprotection in vitro and in vivo by mini circle plasmid containing the human manganese superoxide dismutase (MnSOD) transgene. Hum Gene Ther 19 (2008) 820-826
12. Matthews J.R., Wakasugi N., Virelizier J.L., et al. Thioredoxin regulates the DNA binding activity of NFκB by reduction of the disulphide bond involving cysteine 62. Nucleic Acids Res 20 (1992) 3821-3830
13. Murley J.S., Kataoka Y., Hallahan D.E., et al. Activation of NFκB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells. Free Radic Biol Med 30 (2001) 1426-1439
14. Xu Y., Kiningham K.K., Devalaraja M.N., et al. An intronic NFκB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-α and interleukin 1β. DNA Cell Biol 18 (1999) 709-722
15. Murley J.S., Kataoka Y., Weydert C.J., et al. Delayed cytoprotection after enhancement of Sod2 (MnSOD) gene expression in SA-NH mouse sarcoma cells exposed to WR-1065, the active metabolite of amifostine. Radiat Res 158 (2002) 101-109
16. Murley J.S., Kataoka Y., Cao D., et al. Delayed radioprotection by NF-κB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs. Radiat Res 162 (2004) 536-546
17. Murley J.S., Kataoka Y., Weydert C.J., et al. Delayed radioprotection by nuclear transcription factor κB-mediated induction of manganese superoxide dismutase in human microvascular endothelial cells after exposure to the free radical scavenger WR1065. Free Radic Biol Med 40 (2006) 1004-1016
18. Murley J.S., Kataoka Y., Baker K.L., et al. Manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by the free thiol form of amifostine and tumor necrosis factor α. Radiat Res 167 (2007) 465-474
19. Murley J.S., Nantajit D., Baker K.L., et al. Maintenance of manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by repeated administration of the free thiol form of amifostine. Radiat Res 169 (2008) 494-505
20. Volpe J.P., Hunter B., Basic I., et al. Metastatic properties of murine sarcomas and carcinomas. I. Positive correlation with lung colonization and lack of correlation with s.c. tumor take. Clin Exp Met 3 (1985) 281-294
21. Grdina D.J., Kataoka Y., Murley J.S., et al. Inhibition of spontaneous metastases formation by amifostine. Int J Cancer 97 (2002) 135-141
22. Grdina D.J., Linde S., and Mason K. Response of selected tumor cell populations separated from a fibrosarcoma following irradiation in situ with fast neutrons. Br J Radiol 51 (1978) 291-301
23. Spitz D.R., and Oberley L.W. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 179 (1989) 8-18
24. Aebi H. Catalase in vitro. Methods Enzymol 105 (1984) 121-126
25. Lawrence R.A., and Burk R.F. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 71 (1976) 952-958
26. Stata Statistical Software: Release 10.0 (2007), Stata Corporation, College Station, TX
27. In: Daly L.E., and Bourke G.J. (Eds). Comparison of more than two independent groups. Intrepretation and uses of medical statistics. Fifth edition (2000), Blackwell Science, Oxford, UK 296-338
28. Grdina D.J., Kataoka Y., and Murley J.S. Amifostine: Mechanisms of action underlying cytoprotection and chemoprevention. Drug Metabol Drug Interact 16 (2000) 237-279
29. Shaw L.M., Bonner H.S., and Brown D.Q. Metabolic pathways of WR-2721 (Ethyol, amifostine) in the BALB/c mouse. Drug Metab Dispos 22 (1994) 895-902
30. Shaw L.M., Bonner H.S., Schuchter L., et al. Pharmacokinetics of amifostine: Effects of dose and method of administration. Semin Oncol 26 Suppl 7 (1999) 34-36
31. Lindegaard J.C., and Grau C. Has the outlook improved for amifostine as a clinical radioprotector?. Radiother Oncol 57 (2000) 113-118
32. Brizel D.M., Wasserman T.H., Henke M., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18 (2000) 3339-3345
33. Brizel D.M. Pharmacologic approaches to radiation protection. J Clin Oncol 25 (2007) 4084-4089
34. Sasse A.D., Oliveira Clark L.G., Sasse E.C., et al. Amifostine reduces side effects and improves complete response rate during radiotherapy: Results of a meta-analysis. Int J Radiat Oncol Biol Phys 64 (2006) 784-791
35. Mell L.K., Malik R., Komaki R., et al. Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: A meta-analysis. Int J Radiat Oncol Biol Phys 68 (2007) 111-118